Australia, Jan. 7 -- PRIOVANT THERAPEUTICS Inc., owns the trademark (2569880) for 'BEVALTIA' till July 7, 2033.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis.]
Type of Mark: Word
Date of Acceptance: Sept. 5, 2025
Registration Advertised: Jan. 6
For further details contact Mario De Justo Bailey.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2569880.
Disclaimer: Curated by HT Syndication.
